Replies to post #167703 on Biotech Values

[dewophile]

If ENTA gets approval their EV will be <100M so it won't take much in sales to push up the valuation
i do share some reservations about commercial potential, and it may not be a multibagger or anything, but at this point approval just doesn't seem baked in at all which to me makes this one of the safer bets in biotech